PERAMPANEL (FYCOMPA) FOR TREATMENT OF EPILEPSY (EXPERIENCE OF THE SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
Perampanel (Fycompa, Eisai LLC) is the most recent antiepileptic drug registered for application for additional therapy of patients of 12 y.o. and older with focal and secondary generalized seizures. Perampanel was licensed in the USA and European countries in 2012; it was registered in 2013 and ent...
Saved in:
| Main Authors: | K. Yu. Mukhin, O. A. Pylaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-04-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/35 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New possibilities of using perampanel in children. Efficacy and tolerability of perampanel in the treatment of epilepsy (literature review and experience of Svt. Luka’s Association of Medical Institutions)
by: K. Yu. Mukhin, et al.
Published: (2024-11-01) -
Efficacy and tolerability of Seizar (lamotrigine) in the treatment of epilepsy (experience of Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: O. A. Pylaeva, et al.
Published: (2020-09-01) -
Efficacy and tolerability of rufinamide in the treatment of epilepsy (experience of the Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Yu. Mukhin, et al.
Published: (2018-11-01) -
ZONISAMIDE (ZONEGRAN) IN THE TREATMENT OF EPILEPSY IN ADULTS AND CHILDREN (A REVIEW AND CLINICAL CASE)
by: K. Yu. Мukhin, et al.
Published: (2015-04-01) -
Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01)